Perioperative Intravenous Patient-Controlled Analgesic Efficacy of Morphine with Combined Nefopam and Parecoxib versus Parecoxib in Gynecologic Surgery: A Randomized, Double-Blind Study
Open Access
- 12 February 2021
- journal article
- review article
- Published by Wiley in Anesthesiology Research and Practice
- Vol. 2021, 1-7
Abstract
Background. Nefopam is a non-NSAIDs and opioid sparing centrally acting drug which is effective for a multimodal postoperative analgesia. The present study aimed to evaluate the analgesic efficacy of nefopam combined with parecoxib for gynecologic surgery. Methods. This randomized double-blinded control trial recruited participants (n = 72) who underwent gynecologic surgeries and divided them into either a nefopam or control group. The study group received parecoxib 40 mg plus nefopam 20 mg, while the control group received parecoxib 40 mg plus normal saline solution intravenously during open abdominal gynecological surgery. Both groups then received either nefopam or normal saline every 6 hours postoperatively for 24 hours. Intravenous patient-controlled analgesia with morphine was given for breakthrough pain within 24 h. The participants were evaluated for morphine consumption within 24 hours and postoperative pain using a verbal numerical rating scale (VNRS) at a postanesthetic care unit, at 6-, 12-, and 24-hour postoperative periods. Adverse effects were recorded. Results. Morphine consumption within 24 hours and adverse effects were not significantly different between both groups. Mean difference and 95% confident interval of morphine consumption between both groups was 1.00 (−4.56, 4.76), . The VNRS on movement at 6 hours after surgery of the nefopam group was significantly different from that of the control group [mean (SD), 4.14 (2.11) vs. 5.14 (1.80), ]. The VNRS of the nefopam group at 12 hours after operation during resting and on movement was significantly different from that of the control group ([mean (SD), 1.47 (1.80) vs. 2.54 (2.15), ], [mean (SD), 3.22 (1.84) vs 4.17 (1.74), ]), respectively. Conclusions. The combined administration of nefopam and parecoxib during gynecologic surgery slightly reduced the VNRS at 6 and 12 hours postoperatively more than treatment with parecoxib.Keywords
Funding Information
- Mahidol University (RF-61075)
This publication has 22 references indexed in Scilit:
- The efficacy and safety of nefopam for pain relief during laparoscopic cholecystectomyMedicine, 2018
- The Effect of Nefopam Infusion during Laparascopic Cholecystectomy on Postoperative PainInternational Journal of Medical Sciences, 2017
- Non-opioid analgesics in adults after major surgery: systematic review with network meta-analysis of randomized trialsBritish Journal of Anaesthesia, 2016
- Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studiesClinical and Experimental Pharmacology and Physiology, 2015
- A Randomized Clinical Trial of Nefopam versus Ketorolac Combined With Oxycodone in Patient-Controlled Analgesia after Gynecologic SurgeryInternational Journal of Medical Sciences, 2015
- Single dose oral nefopam for acute postoperative pain in adultsCochrane Database of Systematic Reviews, 2009
- Nefopam for the prevention of postoperative pain: quantitative systematic reviewBritish Journal of Anaesthesia, 2008
- Does Multimodal Analgesia with Acetaminophen, Nonsteroidal Antiinflammatory Drugs, or Selective Cyclooxygenase-2 Inhibitors and Patient-controlled Analgesia Morphine Offer Advantages over Morphine Alone?Anesthesiology, 2005
- Median Effective Dose (ED50) of Nefopam and Ketoprofen in Postoperative PatientsAnesthesiology, 2005
- The Value of ???Multimodal??? or ???Balanced Analgesia??? in Postoperative Pain TreatmentAnesthesia & Analgesia, 1993